T-BSDB-H287 |
Recombinant Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Tandem Diabody) |
Human |
|
CD32B |
malaria antigen |
Inquiry |
T-BSDB-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Tandem Diabody) |
Human |
|
CD32B |
malaria antigen |
Inquiry |
SCIGG-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD32B |
malaria antigen |
Inquiry |
SCIGG-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD32B |
malaria antigen |
Inquiry |
FVTIG-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
CD32B |
malaria antigen |
Inquiry |
FVTIG-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
CD32B |
malaria antigen |
Inquiry |
BSSG-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
CD32B |
malaria antigen |
Inquiry |
BSSG-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
CD32B |
malaria antigen |
Inquiry |
IGLFV-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
CD32B |
malaria antigen |
Inquiry |
IGLFV-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
CD32B |
malaria antigen |
Inquiry |
BSGV-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD32B |
malaria antigen |
Inquiry |
BSGV-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD32B |
malaria antigen |
Inquiry |
BSDG-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
CD32B |
malaria antigen |
Inquiry |
BSDG-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
CD32B |
malaria antigen |
Inquiry |
BABFV-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
CD32B |
malaria antigen |
Inquiry |
BABFV-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
CD32B |
malaria antigen |
Inquiry |
FABVC-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD32B |
malaria antigen |
Inquiry |
FABVC-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD32B |
malaria antigen |
Inquiry |
SCDBC-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
SCDBC-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSDBC-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSDBC-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
SCDBF-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
SCDBF-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSFVF-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSFVF-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSDBF-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSDBF-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSTF-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSTF-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSCFV-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scFv-Fc) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSCFV-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scFv-Fc) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
MNAB-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (Miniantibody) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
MNAB-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Miniantibody) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSFC-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scFv-CH3) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSFC-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scFv-CH3) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSCC-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BSCC-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-based Bispecific Fragments |
CD32B |
malaria antigen |
Inquiry |
BIBD-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (Bibody) |
Human |
Bibody |
CD32B |
malaria antigen |
Inquiry |
BIBD-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Bibody) |
Human |
Bibody |
CD32B |
malaria antigen |
Inquiry |
FABFV-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD32B |
malaria antigen |
Inquiry |
FABFV-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD32B |
malaria antigen |
Inquiry |
MiniB-H289 |
Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (Minibody) |
Human |
Minibody |
CD32B |
malaria antigen |
Inquiry |
MiniB-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Minibody) |
Human |
Minibody |
CD32B |
malaria antigen |
Inquiry |
SCDB-H287 |
Recombinant Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD32B |
malaria antigen |
Inquiry |
FABIG-H287 |
Recombinant Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD32B |
malaria antigen |
Inquiry |
TRIB-H289 |
Recombinant Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD32B |
malaria antigen |
Inquiry |
BSIG-H287 |
Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD32B |
malaria antigen |
Inquiry |
CROSSAB-H287 |
Recombinant Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD32B |
malaria antigen |
Inquiry |
IGFV-H287 |
Recombinant Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD32B |
malaria antigen |
Inquiry |
BSDB-H287 |
Recombinant Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD32B |
malaria antigen |
Inquiry |
BSFAB-H287 |
Recombinant Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD32B |
malaria antigen |
Inquiry |
BSFV-H287 |
Recombinant Human Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD32B |
malaria antigen |
Inquiry |
SCTB-085 |
Recombinant Anti-malaria antigen x Anti-CD32B Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD32B |
malaria antigen |
Inquiry |
SCDB-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD32B |
malaria antigen |
Inquiry |
FABIG-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD32B |
malaria antigen |
Inquiry |
TRIB-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD32B |
malaria antigen |
Inquiry |
BSIG-113 |
Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD32B |
malaria antigen |
Inquiry |
CROSSAB-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD32B |
malaria antigen |
Inquiry |
IGFV-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD32B |
malaria antigen |
Inquiry |
BSDB-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD32B |
malaria antigen |
Inquiry |
BSFAB-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD32B |
malaria antigen |
Inquiry |
BSFV-113 |
Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD32B |
malaria antigen |
Inquiry |
SCDB-H286 |
Recombinant Human Anti-CD32B x Anti-CD79B Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD32B |
CD79B |
Inquiry |
SCDB-H210 |
Recombinant Human Anti-CD16 x Anti-CD32B Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
CD32B |
Inquiry |
FABIG-H305 |
Recombinant Human Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD89 |
malaria antigen |
Inquiry |
FABIG-H301 |
Recombinant Human Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
malaria antigen |
Inquiry |
FABIG-H286 |
Recombinant Human Anti-CD32B x Anti-CD79B Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD32B |
CD79B |
Inquiry |
FABIG-H210 |
Recombinant Human Anti-CD16 x Anti-CD32B Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
CD32B |
Inquiry |
TRIB-H307 |
Recombinant Human Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD89 |
malaria antigen |
Inquiry |
TRIB-H303 |
Recombinant Human Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
malaria antigen |
Inquiry |
TRIB-H288 |
Recombinant Human Anti-CD32B x Anti-CD79B Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD32B |
CD79B |
Inquiry |
TRIB-H212 |
Recombinant Human Anti-CD16 x Anti-CD32B Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD32B |
Inquiry |
BSIG-H305 |
Human Anti-CD89 x Anti-malaria antigen Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD89 |
malaria antigen |
Inquiry |
BSIG-H301 |
Human Anti-CD64 x Anti-malaria antigen Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
malaria antigen |
Inquiry |
BSIG-H286 |
Human Anti-CD32B x Anti-CD79B Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD32B |
CD79B |
Inquiry |
BSIG-H210 |
Human Anti-CD16 x Anti-CD32B Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
CD32B |
Inquiry |
CROSSAB-H305 |
Recombinant Human Anti-CD89 x Anti-malaria antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
malaria antigen |
Inquiry |
CROSSAB-H301 |
Recombinant Human Anti-CD64 x Anti-malaria antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
malaria antigen |
Inquiry |
CROSSAB-H286 |
Recombinant Human Anti-CD32B x Anti-CD79B Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD32B |
CD79B |
Inquiry |
CROSSAB-H210 |
Recombinant Human Anti-CD16 x Anti-CD32B Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
CD32B |
Inquiry |
IGFV-H305 |
Recombinant Human Anti-CD89 x Anti-malaria antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
malaria antigen |
Inquiry |
IGFV-H301 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
malaria antigen |
Inquiry |
IGFV-H286 |
Recombinant Human Anti-CD32B x Anti-CD79B Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD32B |
CD79B |
Inquiry |
IGFV-H210 |
Recombinant Human Anti-CD16 x Anti-CD32B Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
CD32B |
Inquiry |
BSDB-H305 |
Recombinant Human Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
malaria antigen |
Inquiry |
BSDB-H301 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
malaria antigen |
Inquiry |
BSDB-H286 |
Recombinant Human Anti-CD32B x Anti-CD79B Bispecific Antibody (Diabody) |
Human |
Diabody |
CD32B |
CD79B |
Inquiry |
BSDB-H210 |
Recombinant Human Anti-CD16 x Anti-CD32B Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
CD32B |
Inquiry |
BSFAB-H305 |
Recombinant Human Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
malaria antigen |
Inquiry |
BSFAB-H301 |
Recombinant Human Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
malaria antigen |
Inquiry |
BSFAB-H286 |
Recombinant Human Anti-CD32B x Anti-CD79B Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD32B |
CD79B |
Inquiry |
BSFAB-H210 |
Recombinant Human Anti-CD16 x Anti-CD32B Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
CD32B |
Inquiry |
BSFV-H342 |
Recombinant Human Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
malaria antigen |
TLR1 |
Inquiry |
BSFV-H305 |
Recombinant Human Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
malaria antigen |
Inquiry |
BSFV-H301 |
Recombinant Human Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
malaria antigen |
Inquiry |
BSFV-H286 |
Recombinant Human Anti-CD32B x Anti-CD79B Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD32B |
CD79B |
Inquiry |
BSFV-H210 |
Recombinant Human Anti-CD16 x Anti-CD32B Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
CD32B |
Inquiry |
SCTB-102 |
Recombinant Anti-malaria antigen x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
malaria antigen |
CD89 |
Inquiry |
SCTB-097 |
Recombinant Anti-malaria antigen x Anti-CD64 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD64 |
malaria antigen |
Inquiry |
SCDB-181 |
Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
malaria antigen |
TLR1 |
Inquiry |
SCDB-134 |
Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD89 |
malaria antigen |
Inquiry |
SCDB-129 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD64 |
malaria antigen |
Inquiry |
SCDB-112 |
Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD32B |
CD79B |
Inquiry |
SCDB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
CD32B |
Inquiry |
FABIG-181 |
Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
malaria antigen |
TLR1 |
Inquiry |
FABIG-134 |
Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD89 |
malaria antigen |
Inquiry |
FABIG-129 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
malaria antigen |
Inquiry |
FABIG-112 |
Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD32B |
CD79B |
Inquiry |
FABIG-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
CD32B |
Inquiry |
TRIB-181 |
Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
malaria antigen |
TLR1 |
Inquiry |
TRIB-134 |
Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD89 |
malaria antigen |
Inquiry |
TRIB-129 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
malaria antigen |
Inquiry |
TRIB-112 |
Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD32B |
CD79B |
Inquiry |
TRIB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD32B |
Inquiry |
BSIG-181 |
Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
malaria antigen |
TLR1 |
Inquiry |
BSIG-134 |
Anti-CD89 x Anti-malaria antigen Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD89 |
malaria antigen |
Inquiry |
BSIG-129 |
Anti-CD64 x Anti-malaria antigen Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
malaria antigen |
Inquiry |
BSIG-112 |
Anti-CD32B x Anti-CD79B Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD32B |
CD79B |
Inquiry |
BSIG-035 |
Anti-CD16 x Anti-CD32B Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
CD32B |
Inquiry |
CROSSAB-181 |
Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
malaria antigen |
TLR1 |
Inquiry |
CROSSAB-134 |
Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD89 |
malaria antigen |
Inquiry |
CROSSAB-129 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
malaria antigen |
Inquiry |
CROSSAB-112 |
Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD32B |
CD79B |
Inquiry |
CROSSAB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
CD32B |
Inquiry |
IGFV-181 |
Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
malaria antigen |
TLR1 |
Inquiry |
IGFV-134 |
Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD89 |
malaria antigen |
Inquiry |
IGFV-129 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
malaria antigen |
Inquiry |
IGFV-112 |
Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD32B |
CD79B |
Inquiry |
IGFV-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
CD32B |
Inquiry |
BSDB-181 |
Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (Diabody) |
Human |
Diabody |
malaria antigen |
TLR1 |
Inquiry |
BSDB-134 |
Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD89 |
malaria antigen |
Inquiry |
BSDB-129 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
malaria antigen |
Inquiry |
BSDB-112 |
Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (Diabody) |
Human |
Diabody |
CD32B |
CD79B |
Inquiry |
BSDB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
CD32B |
Inquiry |
BSFAB-181 |
Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
malaria antigen |
TLR1 |
Inquiry |
BSFAB-134 |
Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD89 |
malaria antigen |
Inquiry |
BSFAB-129 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
malaria antigen |
Inquiry |
BSFAB-112 |
Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD32B |
CD79B |
Inquiry |
BSFAB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
CD32B |
Inquiry |
BSFV-181 |
Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
malaria antigen |
TLR1 |
Inquiry |
BSFV-134 |
Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD89 |
malaria antigen |
Inquiry |
BSFV-129 |
Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
malaria antigen |
Inquiry |
BSFV-112 |
Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD32B |
CD79B |
Inquiry |
BSFV-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
CD32B |
Inquiry |